A: MedAustron is a synchrotron-based hadron therapy center located in Lower Austria. Accelerated proton beams with energies of 62-252 MeV/u are used to treat patients since 2016. The carbon ion beam is currently under commissioning and will provide treatment in 2019 with energies of 120-400MeV/u. Two of the four irradiation rooms are used for clinical treatment while the preparation of the Gantry beam line is ongoing. Proton beams of up to 800 MeV will be provided for non-clinical research. The Injector features three identical ECRIS from Pantechnik, two of which are used to generate the proton and the carbon beam respectively. The medical environment of the accelerator puts strict requirements on the ion source long-term stability operation. The extracted beam current from the source allow for maximum current fluctuations on the order of ±2.5% on continuous run. In this work we discuss the impact of the ion source performances on the characteristics and stability of the entire accelerator. Further, we discuss the latest progress on carbon commissioning and the future perspectives with particular emphasis on the source requirements. K: Ion sources (positive ions, negative ions, electron cyclotron resonance (ECR), electron beam (EBIS)